NCT00328614: Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer |
|
|
| Completed | 1 | 32 | US | Samarium-153, Samarium-153-ethylene diamine tetramethylene phosphonate, Samarium (153Sm) lexidronam, Quadramet, Total Androgen Suppression (TAS) with Bicalutamide, Casodex, Total androgen suppression (TAS) with Goserelin Acetate, Zoladex, Radiation Therapy, XRT, Radiotherapy | Sidney Kimmel Cancer Center at Thomas Jefferson University, Cytogen Corporation | Prostate Cancer | 02/09 | 06/11 | | |
NCT00631527: Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer |
|
|
| Completed | 1 | 19 | US | Leuprolide, Lupron, Goserelin, Zoladex, Sunitinib Malate, SU011248, Sutent, Casodex, Bicalutamide, Radiation Therapy (RT), Radiotherapy | M.D. Anderson Cancer Center, Pfizer | Prostate Cancer | 01/15 | | | |
